investor.seagen.com investor.seagen.com

investor.seagen.com

Seattle Genetics, Inc.: Investors & News : Investors & News

Transforming cancer treatment and advancing new therapies through empowered science. Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates (ADCs), a technology designed to. 160;033 (0.73%). 5,596,432,697. 08/07/15  4:00 pm ET. Minimum 20 minute delay. Seattle Genetics Reports Second Quarter 2015 Financial Results. 07/30/15 4:30 pm ET.

http://investor.seagen.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTOR.SEAGEN.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 16 reviews
5 star
9
4 star
3
3 star
2
2 star
0
1 star
2

Hey there! Start your review of investor.seagen.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

CONTACTS AT INVESTOR.SEAGEN.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Seattle Genetics, Inc.: Investors & News : Investors & News | investor.seagen.com Reviews
<META>
DESCRIPTION
Transforming cancer treatment and advancing new therapies through empowered science. Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates (ADCs), a technology designed to. 160;033 (0.73%). 5,596,432,697. 08/07/15  4:00 pm ET. Minimum 20 minute delay. Seattle Genetics Reports Second Quarter 2015 Financial Results. 07/30/15 4:30 pm ET.
<META>
KEYWORDS
1 share
2 investors and news
3 press releases
4 stock performance
5 webcasts
6 sec filings
7 financial reports
8 corporate governance
9 analyst coverage
10 investor faq
CONTENT
Page content here
KEYWORDS ON
PAGE
share,investors and news,press releases,stock performance,webcasts,sec filings,financial reports,corporate governance,analyst coverage,investor faq,information request,online ir kit,nasdaq,sgen common stock,high,volume,market cap,events,view event,phone
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Seattle Genetics, Inc.: Investors & News : Investors & News | investor.seagen.com Reviews

https://investor.seagen.com

Transforming cancer treatment and advancing new therapies through empowered science. Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates (ADCs), a technology designed to. 160;033 (0.73%). 5,596,432,697. 08/07/15  4:00 pm ET. Minimum 20 minute delay. Seattle Genetics Reports Second Quarter 2015 Financial Results. 07/30/15 4:30 pm ET.

SOCIAL ENGAGEMENT



OTHER SITES

investor.sciquest.com investor.sciquest.com

Overview | SciQuest

Historic Stock Price Lookup. SciQuest (NASDAQ: SQI) spend management solutions enable procurement, sourcing and financial professionals to focus on strategic decisions that transform business processes. Our feature-rich products and expert services help hundreds of organizations, including leading global companies, drive bottom line results by improving, automating and optimizing their source-to-settle processes. To join the conversation, please visit the SciQuest Blog. Or follow us on Twitter @SciQuest.

investor.scotts.com investor.scotts.com

ScottsMiracle-Gro - Investor Relations - Investor Relations

Give Back to Gro. Media Images and Logos. Q3 2015 The Scotts Miracle-Gro Company Earnings Conference Call. Tuesday, August 04, 2015. 160;at 9:00 am ET. Q3 2015 The Scotts Miracle-Gro Company Earnings Conference Call. Tuesday, August 4, 2015 . 9:00 am ET  . Click here for webcast. Click here to add this event to your calendar. ScottsMiracle-Gro Announces Third Quarter Results; Re-Affirms Full-Year Earnings Outlook. The Scotts Miracle-Gro Company Increases Quarterly Dividend Payment. Scotts Smarter Solutio...

investor.sdchb.com investor.sdchb.com

SDCHB, LLC - Private Moneylending Opportunities

Put Your Money to Work. Learn how you can have your money work for you. Stop working for your money. Simply enter your information in the box below to learn theses groundbreaking high investment strategies that have the potential to change your entire financial future! We value your privacy and would never spam you. Review a quick Overview of the Investment Process:. Have Money to Invest. Considerations for investment: $5,000 – $50,000. You let your money grow for 3 – 6 months. Backed by Real Property.

investor.se investor.se

Welcome to Investor - Investor AB

Investor at a Glance. Listed holdings where we are lead owner. Long ownership horizon and value creation from dividends, value appreciation and cash flow. Our wholly-owned subsidiaries, partner-owned investments and other investments. Mölnlycke Health Care. Risk and Risk Management. Investor and Media Services. We have a long-term perspective for all investments. We always act in the best interest of our portfolio companies by fully supporting them in their efforts to create sustainable value. The Boards...

investor.seagen.com investor.seagen.com

Seattle Genetics, Inc.: Investors & News : Investors & News

Transforming cancer treatment and advancing new therapies through empowered science. Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates (ADCs), a technology designed to. 160;033 (0.73%). 5,596,432,697. 08/07/15  4:00 pm ET. Minimum 20 minute delay. Seattle Genetics Reports Second Quarter 2015 Financial Results. 07/30/15 4:30 pm ET.

investor.seaspine.com investor.seaspine.com

Investors | Investor | SeaSpine

We are a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. We have a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine. 160; 0.25. Data as of 08/17/15 4:00 pm ET. Q2 2015 Seaspine Holdings Corp Earnings Conference Call. 160;at 1:30 pm PT. Thursday, August 13, 2015 .

investor.seattlegenetics.com investor.seattlegenetics.com

Seattle Genetics, Inc.: Investors & News : Investors & News

Transforming cancer treatment and advancing new therapies through empowered science. Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates (ADCs), a technology designed to. 160;245 (5.57%). 5,822,044,765. 08/17/15  4:00 pm ET. Minimum 20 minute delay. Seattle Genetics Reports Second Quarter 2015 Financial Results. 07/30/15 4:30 pm ET. Medical I...

investor.sebi.gov.in investor.sebi.gov.in

:: SEBI Investor | Home ::

Ensure a strong Future. View Financial Education Programs. View articles for various topics. Joint Program with Exchanges/ Depositories/ Trade Bodies. Information to public on complaints. Scheme for conduct of Awareness Programs for Commodities Derivatives. Share and Debenture Holders. Message of the Day. National Strategy for Financial Education. Securities and Exchange Board of India. Reserve Bank of India. Insurance Regulatory and Development Authority. Listed Companies Status - SCORES.

investor.securecapital.dk investor.securecapital.dk

Investor Login |

investor.semirbiz.com investor.semirbiz.com

浙江森马服饰股份有限公司-投资者关系

Zhejiang Semir Garment Co., Ltd. 森马服饰 2012 年 2014 年股东回报规划. 森马服饰 首次公开发行股票 A股 招股说明书.